Breaking News & Company Info

Get access to Genentech information and resources for stories in development. Find recent and archived press releases.

FDA Approval: New Treatment Option for Women with Specific Type of Advanced Ovarian Cancer

Learn More

On December 6, 2016 the FDA approved a medicine for women with platinum-sensitive recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.

Flu Season Resources

On average, 5-20% of the US population gets the flu each year, and more than 200,000 are hospitalized from seasonal flu related complications. To recognize flu symptoms, remember Flu F.A.C.T.S. (Fever, Aches, Chills, (extreme) Tiredness, and Sudden Onset).

View information and materials

2013 ASCO Annual Meeting

Genentech to report new advances at the American Society of Clinical Oncology Annual MeetingGenentech will present important new data from studies of several cancer medicines at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) from May 31-June 4, 2013, in Chicago.This page is intended to be a media resource for Genentech developments at ASCO. It will be updated frequently throughout the meeting.

View information and materials

Erivedge Approved For Advanced Basal Cell Carcinoma

On January 30, 2012, a Genentech medicine was approved by the FDA for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.

View information and materials

Genentech Goes to Town 2010

Genentech Goes to Town takes place September 13 to September 24 in South San Francisco, Vacaville, Oceanside and Hillsboro. The Genentech Goes to Town program supports our communities by providing employees with special "GenenMoney" to spend at local businesses.

View information and materials

Genentech Gives Back Week 2010

Genentech Gives Back Week voluntary activities each day that help Genentech employees collectively make a difference in our communities. All employees are invited to participate in Genentech Gives Back as their time and interest allows.

View information and materials


Load More  

Clinical Trial Data Sharing

As part of our commitment to sharing data from our clinical trials, researchers may request access to analyzable patient-level data. Learn more.